Can low B-vitamin intake, gut absorption stress, and pathway variants amplify homocysteine recycling problems?

Maintaining metabolic health in older adults requires efficient one-carbon metabolism, which is frequently threatened by a combination of dietary, gastrointestinal, and genetic factors.

Systemic and genetic barriers to nutrient availability

• Dietary and gastrointestinal limitations: Low dietary intake directly limits raw B-vitamin substrates, reducing systemic B12 and folate. This is compounded by gut absorption stress, where gastrointestinal pathology, intrinsic factor deficiency, or ileal dysfunction severely curtails the uptake of cobalamin and folate.
• Genetic amplification: Risk alleles in CUBN compromise ileal B12 uptake, while TCN2 variants (such as rs1801198) reduce systemic transport by lowering active holo-transcobalamin levels. Intracellularly, MTRR variants impair the regeneration of active methylcobalamin, and MTR variants lower methionine synthase efficiency, creating a multi-point cascade of cellular depletion.

Impaired homocysteine recycling and cofactor modulation

• Homocysteine accumulation: Deficiencies in cellular B12 and folate status prevent methionine synthase (MTR) from converting homocysteine to methionine. This metabolic block disrupts one-carbon flux, leading directly to hyperhomocysteinemia.
• Riboflavin as a pathway modulator: Riboflavin (Vitamin B2) status serves as a critical modulator in this metabolic network. Optimal riboflavin levels can attenuate or completely rescue the elevated homocysteine risk associated with MTRR and MTHFR polymorphisms.

Bottom line

• Key takeaway: Low dietary intake, gut absorption stress, and genetic variants in CUBN, TCN2, MTRR, and MTR synergistically restrict B12 and folate bioavailability and utilization, causing hyperhomocysteinemia; however, optimizing riboflavin status offers a targeted therapeutic strategy to mitigate genetic risks in this pathway.